Etonogestrel implant in adolescents: evaluation of clinical aspects

Etonogestrel implant in adolescents: evaluation of clinical aspects

Author Guazzelli, Cristina A. F. Autor UNIFESP Google Scholar
Queiroz, Flaviano Teixeira de Autor UNIFESP Google Scholar
Barbieri, Marcia Autor UNIFESP Google Scholar
Torloni, Maria Regina Autor UNIFESP Google Scholar
Araujo, Fabio Fernando de Autor UNIFESP Google Scholar
Institution Universidade Federal de São Paulo (UNIFESP)
Abstract Background: This prospective noncomparative observational study evaluated the clinical aspects of adolescents who received an etonogestrel implant within 6 months of delivery.Study Design: the study population comprised 44 adolescents managed at the Family Planning Sector of São Paulo Federal University. the implant was inserted, on average, 102 days after delivery and patients were followed during 1 year. At each monthly visit to the clinic, the participants were weighed, had their blood pressure measured and were asked to report on symptoms experienced during the last 30 days.Results: Approximately one-third (38.6%) of the participants reported symptoms, mostly headaches. There were no complaints of dysmenorrhea, breast tenderness or lower leg edema throughout the 12 months of follow-up. Mean body weight dropped 1.2 kg on average, from 56.4 kg at implant insertion to 55.3 kg at the end of the 1-year period. Body mass index also decreased 0.5 kg/m(2) on average, although these changes did not reach statistical significance. Systolic and diastolic blood pressure remained unchanged throughout the study period. There were no pregnancies and none of the participants discontinued the method (528 women-months).Conclusion: These findings suggest that the etonogestrel implant is a safe and effective contraceptive method that is well accepted by adolescents after a pregnancy. (C) 2011 Elsevier Inc. All rights reserved.
Keywords Etonogestrel
Contraceptive
Metabolism
Adolescent
Blood pressure
Weight
Postpartum
Language English
Date 2011-04-01
Published in Contraception. New York: Elsevier B.V., v. 83, n. 4, p. 336-339, 2011.
ISSN 0010-7824 (Sherpa/Romeo, impact factor)
Publisher Elsevier B.V.
Extent 336-339
Origin http://dx.doi.org/10.1016/j.contraception.2010.08.004
Access rights Closed access
Type Article
Web of Science ID WOS:000288921100009
URI http://repositorio.unifesp.br/handle/11600/33595

Show full item record




File

File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search


Browse

Statistics

My Account